 1. West Pharmaceutical is a company that specializes in the manufacturing of containment and delivery devices required by customers and patients.
2. West is uniquely positioned to satisfy increasing market demand by leveraging its global operation of scale and resources.
3. The company has recently installed new manufacturing equipment and has additional equipment being installed at a second HVP site with more installations planned in the coming months at other global sites.
4. West's financial results remain strong, with over 18% organic sales growth in the third quarter, partially offset by increased overhead costs.
5. The company's contract manufacturing third-quarter gross profit margin of 17.9% was 350 basis points above the margin achieved in the third quarter of 2019.
6. West has a strong balance sheet, with a cash balance of $519.4 million at September 30, 2020, $80.3 million more than its December 2019 balance.
7. West is expanding its HVP manufacturing capacity at existing sites to meet anticipated 2021 COVID-19 vaccine demand, with capex guidance remaining at $170 million to $180 million.
8. West's sales and earnings per share projections for 2020 and performance are in line with its long-term construct of approximately 6% to